Kambayashi M, Kumada T
Department of Internal Medicine, Faculty of Medicine, Kyoto University.
Nihon Rinsho. 1993 May;51(5):1328-32.
Congestive heart failure (CHF) due to idiopathic cardiomyopathy is reviewed. CHF in dilated cardiomyopathy (DCM) is caused mainly by myocardial systolic dysfunction. Diuretics, angiotensin-converting enzyme (ACE) inhibitors and digitalis are the first choice drugs. ACE inhibitors have been shown to be effective in prolonging life and improving quality of life. Recently, long-term beta-blockade therapy has been shown to be useful. CHF in hypertrophic cardiomyopathy (HCM) is caused by decreased myocardial compliance. The beneficial effect of verapamil in HCM is related to improved relaxation and diastolic filing. Verapamil is also effective in relieving myocardial ischemia. Beta-blockade decreases pressure gradient and oxygen consumption. Idiopathic restrictive cardiomyopathy is a very rare disease and decreased myocardial compliance is responsible for CHF.
本文综述了特发性心肌病所致的充血性心力衰竭(CHF)。扩张型心肌病(DCM)中的CHF主要由心肌收缩功能障碍引起。利尿剂、血管紧张素转换酶(ACE)抑制剂和洋地黄是首选药物。已证明ACE抑制剂在延长寿命和改善生活质量方面有效。最近,长期β受体阻滞剂治疗已显示出有用性。肥厚型心肌病(HCM)中的CHF是由心肌顺应性降低引起的。维拉帕米在HCM中的有益作用与改善舒张和舒张期充盈有关。维拉帕米在缓解心肌缺血方面也有效。β受体阻滞剂可降低压力阶差和氧耗。特发性限制性心肌病是一种非常罕见的疾病,心肌顺应性降低是CHF的原因。